GLP1R and polycystic ovary syndrome: While the studies in this review present promising advancements in the management of patients with PCOS, the limited literature investigating the use of GLP-1 receptor agonists as a specific treatment for PCOS imposes difficulty in determining their utilization as either a monotherapy or in conjunction with standard treatments.